SESSION 1: Update from ARC Fellows

Diagnosis of bacterial infections using a two-gene biomarker signature, Myrsini Kaforou, ARC Fellow, Department of Medicine
Nurse participation in antimicrobial stewardship programmes worldwide: results of a realist literature review and pan-African study, Enrique Castro-Sanchez, ARC Fellow, Department of Medicine
Identification of novel antimicrobial targets in Pseudomonas aeruginosa, Simren Gill, ARC Fellow, Department of Medicine
Policies and strategies for the control of AMR in European healthcare settings, Gabriel Birgand, ARC Fellow, Department of Medicine
Targeting cyclic di-GMP: a strategy to control antimicrobial resistance?, Martina Valentini, ARC Fellow, Department of Life Sciences
Assessing outbreaks of drug-resistant fungi using nanoprone sequencing, Johanna Rhodes, ARC Fellow, School of Public Health

Q&A

Using chromosome conformation metagenomics to look at movement of AMR genes in complex bacterial populations, Mark Holmes, Cambridge Veterinary School 

SESSION 2: Data Linkage and Data Visualisation for Research and Policy

Title TBC - Speaker TBC
Title TBC - David Aanensen, School of Public Health
Data Visualisation for AMR, Ceire Costelloe, Department of Medicine

Q&A

SESSION 3: Identifying Targets

Pathogen adaptation to the gastrointestinal environment during antimicrobial chemotherapy, Gad Frankel, Department of Life Sciences
A novel, potent, resistance-breaking antimicrobial, targeting the host cell modification machinery, Ed Tate, Department of Chemistry
Metabolomics to accelerate antibacterial target identification and mechanism-of-action studies, Luis Carvalho, The Francis Crick Institute

Questions and Answers

SESSION 4: Understanding Emergence of Resistance

Emergence of Carbapenemase -producing Enterobacteriaceae (CPE): control, colistin and cost, Jon Otter, Imperial College Healthcare NHS Trust
A novel mechanism of antibiotic resistance in Staphylococcus aureus, Andrew Edwards, Department of Medicine
Emerging global threat of antifungal resistance in Aspergillus fumigatus, Darius Armstrong-James, National Heart and Lung Institute

Q&A

SESSION 5: Innovation in Technology for Diagnosis and Dosing

Horizon scanning of diagnostic technologies for emerging infectious diseases and AMR, Jesus Rodriguez-Manzano, Department of Electrical and Electronic Engineering
Precision antimicrobial delivery using closed-loop continuous control, Tony Cass, Department of Chemistry and Tim Rawson, Department of Medicine

Q&A